Acenocoumarol or warfarin

Which is the clinician’s ally?

N. Karthik Rao, Navin Patil, A. Avinash, Handattu Manjunatha Hande, Sushil Kiran Kunder, N. Raghavendra Rao

Research output: Contribution to journalArticle

Abstract

Warfarin and acenocoumarol are commonly prescribed oral anticoagulant drugs that are used in the prevention and treatment of thromboembolic disorders across the world. Although both these drugs act by a similar mechanism, there are significant differences between them, especially in terms of their half-lives, and more importantly, in their variability in response pharmacogenetically. This case report highlights an instance wherein warfarin proved to provide a much more stable anticoagulant cover, as compared to that provided by acenocoumarol.

Original languageEnglish
Pages (from-to)4-5
Number of pages2
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume9
Issue number2
Publication statusPublished - 01-03-2016

Fingerprint

Acenocoumarol
Warfarin
Anticoagulants
Pharmaceutical Preparations
metsulfuron methyl

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

Karthik Rao, N., Patil, N., Avinash, A., Hande, H. M., Kunder, S. K., & Raghavendra Rao, N. (2016). Acenocoumarol or warfarin: Which is the clinician’s ally? Asian Journal of Pharmaceutical and Clinical Research, 9(2), 4-5.
Karthik Rao, N. ; Patil, Navin ; Avinash, A. ; Hande, Handattu Manjunatha ; Kunder, Sushil Kiran ; Raghavendra Rao, N. / Acenocoumarol or warfarin : Which is the clinician’s ally?. In: Asian Journal of Pharmaceutical and Clinical Research. 2016 ; Vol. 9, No. 2. pp. 4-5.
@article{33d1c0612bd94c8b82bc0331cfdd0f9d,
title = "Acenocoumarol or warfarin: Which is the clinician’s ally?",
abstract = "Warfarin and acenocoumarol are commonly prescribed oral anticoagulant drugs that are used in the prevention and treatment of thromboembolic disorders across the world. Although both these drugs act by a similar mechanism, there are significant differences between them, especially in terms of their half-lives, and more importantly, in their variability in response pharmacogenetically. This case report highlights an instance wherein warfarin proved to provide a much more stable anticoagulant cover, as compared to that provided by acenocoumarol.",
author = "{Karthik Rao}, N. and Navin Patil and A. Avinash and Hande, {Handattu Manjunatha} and Kunder, {Sushil Kiran} and {Raghavendra Rao}, N.",
year = "2016",
month = "3",
day = "1",
language = "English",
volume = "9",
pages = "4--5",
journal = "Asian Journal of Pharmaceutical and Clinical Research",
issn = "0974-2441",
publisher = "Innovare Academics Sciences Pvt. Ltd",
number = "2",

}

Karthik Rao, N, Patil, N, Avinash, A, Hande, HM, Kunder, SK & Raghavendra Rao, N 2016, 'Acenocoumarol or warfarin: Which is the clinician’s ally?', Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 2, pp. 4-5.

Acenocoumarol or warfarin : Which is the clinician’s ally? / Karthik Rao, N.; Patil, Navin; Avinash, A.; Hande, Handattu Manjunatha; Kunder, Sushil Kiran; Raghavendra Rao, N.

In: Asian Journal of Pharmaceutical and Clinical Research, Vol. 9, No. 2, 01.03.2016, p. 4-5.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Acenocoumarol or warfarin

T2 - Which is the clinician’s ally?

AU - Karthik Rao, N.

AU - Patil, Navin

AU - Avinash, A.

AU - Hande, Handattu Manjunatha

AU - Kunder, Sushil Kiran

AU - Raghavendra Rao, N.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Warfarin and acenocoumarol are commonly prescribed oral anticoagulant drugs that are used in the prevention and treatment of thromboembolic disorders across the world. Although both these drugs act by a similar mechanism, there are significant differences between them, especially in terms of their half-lives, and more importantly, in their variability in response pharmacogenetically. This case report highlights an instance wherein warfarin proved to provide a much more stable anticoagulant cover, as compared to that provided by acenocoumarol.

AB - Warfarin and acenocoumarol are commonly prescribed oral anticoagulant drugs that are used in the prevention and treatment of thromboembolic disorders across the world. Although both these drugs act by a similar mechanism, there are significant differences between them, especially in terms of their half-lives, and more importantly, in their variability in response pharmacogenetically. This case report highlights an instance wherein warfarin proved to provide a much more stable anticoagulant cover, as compared to that provided by acenocoumarol.

UR - http://www.scopus.com/inward/record.url?scp=84960089700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960089700&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 4

EP - 5

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

SN - 0974-2441

IS - 2

ER -

Karthik Rao N, Patil N, Avinash A, Hande HM, Kunder SK, Raghavendra Rao N. Acenocoumarol or warfarin: Which is the clinician’s ally? Asian Journal of Pharmaceutical and Clinical Research. 2016 Mar 1;9(2):4-5.